Results 121 to 130 of about 12,602 (147)

Architecture and regulatory functions of c-di-GMP signaling in classical Bordetella species. [PDF]

FEMS Microbiol Rev
Vondrova D, Mugni SL, Blumenstein J, Kasiztky C, Sisti F, Fernández J, Kamanova J.   +6 more
europepmc   +1 more source

A PDE4 shortform degrader: a first in isoform-specific PDE4 inhibition. [PDF]

FEBS J
Maurice DH.
europepmc   +1 more source

Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation. [PDF]

Clin Pharmacol
Ma Q, Zhou S, Zhi X, Luo C, Zhu Z, Zhang X, Liu X.   +6 more
europepmc   +1 more source

Discovery of natural CdnP inhibitors through structure-based virtual screening and molecular dynamics simulations. [PDF]

Microbiol Spectr
Gu X, Xiong C, Wang X, Zhu H, Sun W, He Y, Zhang J.   +6 more
europepmc   +1 more source

New Zealand (NZ)'s Medsafe has advised prescribers of the risk of sudden deafness associated with type 5 cyclic nucleotide phosphodiesterase inhibitors,

Reactions Weekly, 2009
openaire   +1 more source

Cyclic nucleotide-induced helical structure activates a TIR immune effector

Nature, 2022
Gaelle Hogrel, Abbie Guild, Shirley Graham   +2 more
exaly  

A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction

Circulation, 2020
Si Chen, Yishuai Zhang, Jiangbin Wu
exaly  

Advances in targeting cyclic nucleotide phosphodiesterases

Nature Reviews Drug Discovery, 2014
Hengming Ke, Faiyaz Ahmad, Yousheng Wang
exaly  

Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond

Nature Reviews Drug Discovery, 2019
Gonzalo S Tejeda, Michy P Kelly
exaly